192 related articles for article (PubMed ID: 8088182)
1. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
Lu CD; Qi YG; Peng SY
Chin Med J (Engl); 1994 Mar; 107(3):209-15. PubMed ID: 8088182
[TBL] [Abstract][Full Text] [Related]
2. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of preoperative transcatheter arterial embolization for improved survival rates in patients with hepatocellular carcinomas (sandwich therapy using ethiodized oil, cisplatin and gelatin sponge].
Shibata T; Sasaki Y; Imaoka S; Yasuda T; Wada H; Ishikawa O; Ohigashi H; Fukuda I; Kabuto T; Hiratsuka M
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2514-9. PubMed ID: 2843115
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
6. [The role of antineoplastic solution in transcatheter hepatic arterial embolization--in terms of survival rates affecting anticancer agents together with gelatin sponge].
Yamada R; Tsuda M; Sato M; Nakayama T; Nishioka S; Yataka I; Nakamura K; Onoyama Y; Kanno T; Nakatsuka H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2621-6. PubMed ID: 2843130
[TBL] [Abstract][Full Text] [Related]
7. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
[TBL] [Abstract][Full Text] [Related]
8. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
9. [Chemoembolization].
Nakamura H; Hashimoto T; Taguchi T; Oi H; Nakagawa K; Inoue K; Seki K; Mizumoto S; Akashi H; Tsukaguchi I
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1656-63. PubMed ID: 3036013
[TBL] [Abstract][Full Text] [Related]
10. [Value of mixed embolus transarterial chemoembolization in the treatment of hepatocellular carcinoma].
Li CR; Jiang WH; Feng XM; Guo YJ; Shi ZH; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):557-60. PubMed ID: 16438857
[TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
13. [Oily chemoembolization of hepatoma].
Nakamura H; Hashimoto T; Taguchi T; Oi H; Inoue K; Seki K; Mizumoto S; Tsukaguchi I; Araki Y; Sawada S
Gan To Kagaku Ryoho; 1987 Feb; 14(2):381-7. PubMed ID: 3028276
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic arterial infusion chemotherapy and embolization in the treatment of hepatic carcinoma].
Wang ZY; Shi ZH; Zai RY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):454-7. PubMed ID: 7720505
[TBL] [Abstract][Full Text] [Related]
16. [Combined hepatic-artery and portal-vein chemoembolization for colorectal cancer metastatic to the liver].
Tarazov PG; Granov DA; Polikarpov AA; Polisalov VN; Borovik VV
Vopr Onkol; 2002; 48(1):83-7. PubMed ID: 12101575
[TBL] [Abstract][Full Text] [Related]
17. [-Comparison of lipiodol-assisted chemoembolization versus only conservative therapy in patients with nonresectable hepatocellular carcinomas-].
Lorenz M; Waldeyer M; Müller HH
Z Gastroenterol; 1996 Mar; 34(3):205-6. PubMed ID: 8650976
[No Abstract] [Full Text] [Related]
18. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
[TBL] [Abstract][Full Text] [Related]
20. [Combined arterial and intraportal therapy of hepatocellular carcinoma: preliminary results].
Tarazov PG; Prozorovskiĭ KV; Polysalov VN
Vopr Onkol; 1994; 40(7-12):349-53. PubMed ID: 7610635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
